Cell death targeting therapies in B lymphoid malignancies

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Programmed cell death (apoptosis) is crucial for maintaining lymphoid tissue homeostasis.
• Dysregulation of apoptosis is a hallmark of lymphoid malignancies, enabling tumor cells to evade chemotherapy.
• Ineffective apoptosis in B lymphoid tumors presents a therapeutic challenge.

Purpose of the Study:

• To review current therapeutic strategies that induce cell death in B lymphoid neoplasms.
• To highlight novel approaches targeting the apoptotic machinery or its regulatory factors.

Main Methods:

• Review of current literature on apoptosis and B lymphoid malignancies.
• Analysis of therapeutic strategies targeting key molecules in cell death pathways.
• Focus on therapies progressing to clinical testing or approved.

Main Results:

• Significant progress in understanding deregulated apoptosis in B lymphoid tumors.
• Development of novel strategies to modulate apoptosis.
• Several new therapies are in clinical trials or have received approval.

Conclusions:

• Targeting apoptosis offers a promising avenue for treating B lymphoid neoplasms.
• Modulating key molecules of life-and-death decisions can overcome therapeutic resistance.
• Emerging therapies demonstrate efficacy in triggering cell death in lymphoid malignancies.